Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Kinney

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Journal of Alzheimer'S Disease : JAD|November 19, 2023
Microglial Imaging in Alzheimer's Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET StudyZhengshi Yang, Sarah J Banks, Aaron R Ritter, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 20, 2026
Biomarkers in Alzheimer's disease clinical trials: 2025Amanda M Leisgang Osse, Yadi Zhou, Jefferson W Kinney, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 22, 2021
Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementiaDawn C Matthews, Aaron Ritter, Ronald G Thomas, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 18, 2003
Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-mazeAndrew Holmes, Jefferson W Kinney, Craige C Wrenn, et al.
The Journal of Prevention of Alzheimer'S Disease|May 11, 2022
Dual Task Performance Is Associated with Amyloidosis in Cognitively Healthy AdultsJ K Longhurst, J L Cummings, S E John, et al.
The European Journal of Neuroscience|March 16, 2004
Learning and memory performance in mice lacking the GAL-R1 subtype of galanin receptorCraige C Wrenn, Jefferson W Kinney, Lisa K Marriott, et al.
Alzheimer'S Research & Therapy|November 4, 2023
Clinical and biological relevance of glial fibrillary acidic protein in Alzheimer's diseaseZhengshi Yang, Karthik Sreenivasan, Erin N Toledano Strom, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 11, 2024
Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patientsDawn C Matthews, Jefferson W Kinney, Aaron Ritter, et al.
Neuropeptides|June 10, 2005
Galanin impairs performance on learning and memory tasks: findings from galanin transgenic and GAL-R1 knockout miceNathan R Rustay, Craige C Wrenn, Jefferson W Kinney, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Journal of Alzheimer'S Disease : JAD|November 19, 2023
Microglial Imaging in Alzheimer's Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET StudyZhengshi Yang, Sarah J Banks, Aaron R Ritter, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 20, 2026
Biomarkers in Alzheimer's disease clinical trials: 2025Amanda M Leisgang Osse, Yadi Zhou, Jefferson W Kinney, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 22, 2021
Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementiaDawn C Matthews, Aaron Ritter, Ronald G Thomas, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 18, 2003
Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-mazeAndrew Holmes, Jefferson W Kinney, Craige C Wrenn, et al.
The Journal of Prevention of Alzheimer'S Disease|May 11, 2022
Dual Task Performance Is Associated with Amyloidosis in Cognitively Healthy AdultsJ K Longhurst, J L Cummings, S E John, et al.
The European Journal of Neuroscience|March 16, 2004
Learning and memory performance in mice lacking the GAL-R1 subtype of galanin receptorCraige C Wrenn, Jefferson W Kinney, Lisa K Marriott, et al.
Alzheimer'S Research & Therapy|November 4, 2023
Clinical and biological relevance of glial fibrillary acidic protein in Alzheimer's diseaseZhengshi Yang, Karthik Sreenivasan, Erin N Toledano Strom, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 11, 2024
Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patientsDawn C Matthews, Jefferson W Kinney, Aaron Ritter, et al.
Neuropeptides|June 10, 2005
Galanin impairs performance on learning and memory tasks: findings from galanin transgenic and GAL-R1 knockout miceNathan R Rustay, Craige C Wrenn, Jefferson W Kinney, et al.
Pageof 8